Request Deal Involvement

ANI Pharmaceuticals to acquire Novitium Pharma for $210m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Leerink Partners

financial advisors

Leerink Partners

Orrick Herrington & Sutcliffe

legal advisors

Orrick Herrington & Sutcliffe

In-Site Communications

pr advisors

In-Site Communications

Bourne Partners

financial advisors

Bourne Partners

Truist Securities

financial advisors

Truist Securities

Houlihan Lokey

financial advisors

Houlihan Lokey

Hughes Hubbard & Reed

legal advisors

Hughes Hubbard & Reed

Alston & Bird

legal advisors to financial advisors

Alston & Bird

Shearman & Sterling

legal advisors to financial advisors

Shearman & Sterling

or

Principals

NOVITIUM PHARMA

target

NOVITIUM PHARMA

ANI PHARMACEUTICALS

bidder

ANI PHARMACEUTICALS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite